Clinical Trials Directory

Trials / Unknown

UnknownNCT02646462

Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer

Systematic Lymph Node Sampling and Analysis in Patients Undergoing Radical Resection for Pancreatic Cancer. A National Danish Study

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Michael Bau Mortensen · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Prospective investigation of the ratio between malignant and total number of lymph nodes in predefined lymph node stations in patients resected for pancreatic adenocarcinoma. A national Danish project.

Detailed description

Lymph nodes will be sampled from the following stations in patients with adenocarcinomas of the pancreas Group 6: Infrapyloric lymph nodes (IP) Group 8: Lymph nodes around the common hepatic artery (CHA) Group 12: Lymph nodes of the hepatoduodenal ligament (HDL) Group 13: Posterior pancreaticoduodenal lymph nodes Group 14: Lymph nodes around the superior mesenteric artery (SMA) Group 17: Anterior pancreaticoduodenal lymph nodes

Conditions

Timeline

Start date
2015-06-01
Primary completion
2016-06-01
Completion
2016-12-01
First posted
2016-01-05
Last updated
2016-01-07

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02646462. Inclusion in this directory is not an endorsement.

Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer (NCT02646462) · Clinical Trials Directory